Insider Buying: Proteome Sciences plc (PRM) Insider Acquires £20,000 in Stock

Proteome Sciences plc (LON:PRM) insider Martin Diggle bought 500,000 shares of the firm’s stock in a transaction dated Monday, August 13th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £20,000 ($25,513.46).

Martin Diggle also recently made the following trade(s):

  • On Wednesday, August 1st, Martin Diggle bought 328,000 shares of Proteome Sciences stock. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £13,120 ($16,736.83).

Shares of LON PRM opened at GBX 3.62 ($0.05) on Friday. Proteome Sciences plc has a 12-month low of GBX 2.61 ($0.03) and a 12-month high of GBX 5.64 ($0.07).

Separately, FinnCap restated a “corporate” rating and set a GBX 7 ($0.09) target price on shares of Proteome Sciences in a research report on Tuesday, April 24th.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes.

Further Reading: Market Capitalization – What it Means for Investors

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply